Profound Medical (PROF) announces that the first commercial benign prostatic hyperplasia, BPH, treatment utilizing the TULSA-PRO system’s new TULSA-AI Volume Reduction Module was successfully conducted yesterday by Naveen Kella, M.D., Founder of The Urology Place and an Adjunct Assistant Professor for the UT Health Science Center San Antonio.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROF:
- Profound Medical Partners with NFL Legend Leonard Wheeler to Promote TULSA-PRO
- Profound Medical enters agreement with former NFL player Leonard Wheeler
- Profound Medical Corp. Announces Successful Shareholder Meeting Outcomes
- Profound Medical’s Earnings Call Highlights Growth and Innovation
- Profound Medical downgraded to Outperform from Strong Buy at Raymond James